HomePTPI • NASDAQ
add
Petros Pharmaceuticals Inc
Previous close
$0.64
Day range
$0.64 - $0.66
Year range
$0.60 - $5.24
Market cap
4.40M USD
Avg Volume
751.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | -364.25K | -145.64% |
Operating expense | 4.52M | 12.40% |
Net income | 318.15K | 107.54% |
Net profit margin | -87.34 | 83.49% |
Earnings per share | — | — |
EBITDA | -4.24M | -33.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.34M | 41.49% |
Total assets | 33.80M | 4.24% |
Total liabilities | 21.32M | 35.61% |
Total equity | 12.48M | — |
Shares outstanding | 6.88M | — |
Price to book | 0.16 | — |
Return on assets | -34.65% | — |
Return on capital | -69.02% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 318.15K | 107.54% |
Cash from operations | -2.26M | -43.91% |
Cash from investing | — | — |
Cash from financing | -2.37M | -1,182.34% |
Net change in cash | -4.63M | -163.93% |
Free cash flow | 24.90K | 123.02% |
About
Founded
2020
Website
Employees
21